CONSOLIDATED CONDENSED STATEMENTS OF OPERATIONS - USD ($) shares in Millions, $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2025	Sep. 30, 2024	Sep. 30, 2025	Sep. 30, 2024
Income Statement [Abstract]
Net sales	$ 1,553.1	$ 1,354.4	$ 4,498.0	$ 4,053.7
Cost of sales	345.2	262.9	991.2	825.3
Gross profit	1,207.9	1,091.5	3,506.8	3,228.4
Selling, general, and administrative expenses	514.6	421.4	1,482.3	1,297.3
Research and development expenses	280.7	253.4	811.5	781.9
Certain litigation expenses	90.4	10.8	116.8	27.8
Change in fair value of contingent consideration liabilities	(12.5)	0.0	(12.5)	0.0
Restructuring charges and separation costs (Note 3)	0.1	32.9	8.5	32.9
Intangible assets impairment charges	40.0	0.0	40.0	0.0
Other operating (income) expense, net	(12.5)	22.4	(52.9)	22.4
Operating income, net	307.1	350.6	1,113.1	1,066.1
Interest income, net	(38.6)	(24.3)	(112.5)	(56.3)
Loss on impairment (Note 6)	0.0	0.0	47.1	0.0
Other non-operating income, net	(2.7)	(27.9)	(4.0)	(35.6)
Income from continuing operations before provision for income taxes	348.4	402.8	1,182.5	1,158.0
Provision for income taxes	56.1	40.7	190.7	107.0
Net income from continuing operations	292.3	362.1	991.8	1,051.0
(Loss) income from discontinued operations, net of tax	(2.0)	2,707.3	(13.6)	2,734.4
Net income	290.3	3,069.4	978.2	3,785.4
Net loss attributable to noncontrolling interest	(0.8)	(1.4)	(4.1)	(3.6)
Net income attributable to Edwards Lifesciences Corporation	$ 291.1	$ 3,070.8	$ 982.3	$ 3,789.0
Basic:
Continuing operations (in dollars per share)	$ 0.50	$ 0.61	$ 1.70	$ 1.76
Discontinued operations (in dollars per share)	0	4.53	(0.02)	4.55
Basic earnings per share (in dollars per share)	0.50	5.14	1.68	6.31
Diluted:
Continuing operations (in dollars per share)	0.50	0.61	1.70	1.75
Discontinued operations (in dollars per share)	0	4.52	(0.03)	4.54
Diluted earnings per share (in dollars per share)	$ 0.50	$ 5.13	$ 1.67	$ 6.29
Weighted-average number of common shares outstanding:
Basic (in shares)	584.7	597.2	586.2	600.3
Diluted (in shares)	585.7	598.1	587.2	602.2